Comments
Loading...

Entera Bio

ENTXNASDAQ
Logo brought to you by Benzinga Data
$2.10
-0.02-0.94%
At Close: -
$2.10
00.00%
After Hours: Sep 17, 4:28 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$5.00
Consensus Price Target1
$7.50

Entera Bio (NASDAQ:ENTX) Stock, Analyst Ratings, Price Targets, Forecasts

Entera Bio Ltd has a consensus price target of $7.5 based on the ratings of 2 analysts. The high is $10 issued by HC Wainwright & Co. on August 12, 2024. The low is $5 issued by B. Riley Securities on July 19, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on August 12, 2024, June 5, 2024, and May 14, 2024, respectively. With an average price target of $10 between HC Wainwright & Co., there's an implied 376.19% upside for Entera Bio Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Jun
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
B. Riley Securities

1calculated from analyst ratings

Analyst Ratings for Entera Bio

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Entera Bio (ENTX) stock?

A

The latest price target for Entera Bio (NASDAQ:ENTX) was reported by HC Wainwright & Co. on August 12, 2024. The analyst firm set a price target for $10.00 expecting ENTX to rise to within 12 months (a possible 376.19% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Entera Bio (ENTX)?

A

The latest analyst rating for Entera Bio (NASDAQ:ENTX) was provided by HC Wainwright & Co., and Entera Bio reiterated their buy rating.

Q

When was the last upgrade for Entera Bio (ENTX)?

A

There is no last upgrade for Entera Bio

Q

When was the last downgrade for Entera Bio (ENTX)?

A

There is no last downgrade for Entera Bio.

Q

When is the next analyst rating going to be posted or updated for Entera Bio (ENTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Entera Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Entera Bio was filed on August 12, 2024 so you should expect the next rating to be made available sometime around August 12, 2025.

Q

Is the Analyst Rating Entera Bio (ENTX) correct?

A

While ratings are subjective and will change, the latest Entera Bio (ENTX) rating was a reiterated with a price target of $10.00 to $10.00. The current price Entera Bio (ENTX) is trading at is $2.10, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.